Trial record 1 of 1 for:
2020-004848-29
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04777396 |
Recruitment Status :
Active, not recruiting
First Posted : March 2, 2021
Last Update Posted : April 30, 2024
|
Sponsor:
Novo Nordisk A/S
Information provided by (Responsible Party):
Novo Nordisk A/S
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Estimated Primary Completion Date : | September 19, 2025 |
Estimated Study Completion Date : | October 23, 2026 |